Sign in

CIK 0000728387

  • Non-accelerated filer
  • Smaller reporting company

Perspective Therapeutics, Inc.

Sign in to watch
Ticker
CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411458152
Phone
+1 206-676-0900
Business address
2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
Former names
IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
  1. 4 Open-market buy Director bought 75,954 shares at an average $0.25 ($19,363)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Director bought 4,200 shares at $0.89 ($3,738)
  5. 4/A Open-market buy Interim CEO bought 5,000 shares at $0.89 ($4,450)
  6. 4 Open-market buy Acting COO bought 5,000 shares at an average $0.90 ($4,500)
  7. 4 Open-market buy Interim CEO bought 5,000 shares at $0.89 ($4,450)
  8. 4 Open-market buy EVP Operations & Secretary bought 3,500 shares at $1.21 ($4,235)
  9. 4 Open-market buy Director bought 9,000 shares at an average $2.43 ($21,900)
  10. 4 Open-market buy EVP Operations & Secretary bought 600 shares at $2.21 ($1,326)
  11. 4 Open-market buy CEO & President bought 2,500 shares at an average $2.40 ($6,010)
  12. 4 Open-market buy Director bought 20,000 shares at $2.25 ($45,000)
  13. 4 Open-market buy EVP Operations & Secretary bought 15,200 shares at an average $2.28 ($34,588)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 15 of 18 · 341 filings